Clinical Trials Browser

Phase 2 × Meningioma × vistusertib × Clear all

NCT03071874 2022-10-18

Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas

Phase 2 Unknown

Meningioma

NCT02831257 2022-06-13

AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas

Phase 2 Completed

18 enrolled 13 charts

Meningioma, Neurofibromatosis 2